Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader
in the development and sale of broadly enabling, pressure-based technology and
products to the worldwide life sciences and other industries, on Tuesday
announced that it will host a teleconference to discuss its second quarter 2019
financial results and to provide a business update. The teleconference is
scheduled for 4:30 PM ET on Thursday, August 15, 2019, and will include a
company presentation followed by a question and answer period. Interested
parties may listen to the teleconference live by dialing (844) 602-0380 (North
America); (862) 298-0970 (International) and entering the following verbal
passcode for the operator: PBI Second Quarter 2019 Financial Call and Business
Update. For those unable to participate in the live teleconference, a replay
will be available beginning Friday, August 16, 2019, and will be accessible via
telephone and the company’s website for 30 days. Interested parties may listen
to the replay by dialing (877) 481-4010 (North America); (919) 882-2331
(International) and entering replay passcode: 53312.
To view the full press release, visit http://ibn.fm/7IZxr
About Pressure BioSciences Inc.
Pressure BioSciences (OTCQB: PBIO) is a leader in the
development and sale of innovative, broadly enabling, pressure-based solutions
for the worldwide life-sciences industry. The company’s products are based on
the unique properties of both constant (i.e., static) and alternating (i.e.,
pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a
patented-enabling technology platform that uses alternating cycles of
hydrostatic pressure between ambient and ultra-high levels to safely and
reproducibly control biomolecular interactions (e.g., cell lysis, biomolecule
extraction). PBIO’s primary focus is in the development of PCT-based products
for biomarker and target discovery, drug design and development, biotherapeutics
characterization and quality control, soil and plant biology, forensics and
counter-bioterror applications. Additionally, major new market opportunities
have emerged in the use of the company’s pressure-based technologies in the
following areas: (1) the use of its recently acquired PreEMT technology from
BaroFold Inc. to allow entry into the biologics-contract, research-services
sector, and (2) the use of its recently patented, scalable, high-efficiency,
pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable
nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and (ii)
prepare higher-quality, homogenized, extended shelf-life or room-temperature
stable, low-acid liquid foods that cannot be effectively preserved using existing
nonthermal technologies. For more information, visit the company’s website
at www.PressureBiosciences.com.
NOTE TO INVESTORS: The latest news and updates
relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment